Cargando…
Accelerating the development of biomarkers for drug safety : workshop summary /
"Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has risen in recent years, reducing the number of new drugs approved for use, biomarker development may be a way to cut costs, enhance safety, and prov...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Washington, D.C. :
National Academies Press,
©2009.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn427878159 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 090727s2009 dcua ob 100 0 eng d | ||
| 040 | |a MMU |b eng |e pn |c MMU |d CDX |d N$T |d IDEBK |d OCLCQ |d E7B |d CU3 |d OCLCQ |d WVH |d OCLCQ |d COO |d YDXCP |d OCLCA |d OCLCF |d OCLCQ |d OCLCO |d NLGGC |d OCL |d OCLCO |d OCLCQ |d EBLCP |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO |d AZK |d OCLCO |d OCLCA |d OCLCO |d LOA |d OCLCA |d VT2 |d OCLCQ |d TOA |d OCLCO |d AGLDB |d OCLCO |d MOR |d PIFAG |d OCLCQ |d ZCU |d OCLCO |d OCLCQ |d MERUC |d OCLCO |d OCLCQ |d NJR |d OCLCO |d MERER |d OCLCO |d OCLCA |d U3W |d OCLCA |d BUF |d OCLCO |d OCLCQ |d OCLCO |d CUY |d KIJ |d OCLCO |d OCLCQ |d STF |d WRM |d VNS |d OCLCO |d OCLCQ |d VTS |d COCUF |d NRAMU |d EZ9 |d OCLCQ |d ICG |d OCLCO |d AU@ |d OCLCO |d OCLCQ |d S9I |d WYU |d TKN |d OCLCO |d OCLCQ |d DKC |d OCLCO |d OCLCQ |d M8D |d UX1 |d UKAHL |d OCLCQ |d OCLCA |d UKCRE |d VLY |d OCLCQ |d SDF |d TUHNV |d OCLCO |d DST |d SFB |d OCLCO |d OCLCQ |d OCL |d OCLCO |d INARC |d OCLCA |d OCLCL | ||
| 016 | 7 | |a 101518373 |2 DNLM | |
| 019 | |a 441969242 |a 741345471 |a 816322329 |a 923280588 |a 961545365 |a 962637389 |a 966243659 |a 971070095 |a 988411953 |a 992109440 |a 1021249935 |a 1028775238 |a 1037940539 |a 1038692096 |a 1045501682 |a 1047528237 |a 1048131430 |a 1055336146 |a 1063799329 |a 1081257008 |a 1119441791 |a 1119513554 |a 1153503450 |a 1156373658 |a 1162567391 |a 1200916675 |a 1204386208 |a 1204392903 |a 1228577044 |a 1249254461 |a 1290090275 |a 1300705903 |a 1412396172 | ||
| 020 | |a 9780309131254 |q (electronic bk.) | ||
| 020 | |a 0309131251 |q (electronic bk.) | ||
| 020 | |a 0309131243 |q (pbk.) | ||
| 020 | |a 9780309131247 |q (pbk.) | ||
| 020 | |a 1282272659 | ||
| 020 | |a 9781282272651 | ||
| 020 | |a 9786612272653 | ||
| 020 | |a 6612272651 | ||
| 020 | |a 0309142318 | ||
| 020 | |a 9780309142311 | ||
| 020 | |z 9780309131247 | ||
| 029 | 1 | |a AU@ |b 000051451224 | |
| 029 | 1 | |a CDX |b 10729834 | |
| 029 | 1 | |a DEBBG |b BV043132598 | |
| 029 | 1 | |a DEBBG |b BV044108956 | |
| 029 | 1 | |a DEBSZ |b 421954728 | |
| 029 | 1 | |a HEBIS |b 278022952 | |
| 029 | 1 | |a NZ1 |b 13934108 | |
| 035 | |a (OCoLC)427878159 |z (OCoLC)441969242 |z (OCoLC)741345471 |z (OCoLC)816322329 |z (OCoLC)923280588 |z (OCoLC)961545365 |z (OCoLC)962637389 |z (OCoLC)966243659 |z (OCoLC)971070095 |z (OCoLC)988411953 |z (OCoLC)992109440 |z (OCoLC)1021249935 |z (OCoLC)1028775238 |z (OCoLC)1037940539 |z (OCoLC)1038692096 |z (OCoLC)1045501682 |z (OCoLC)1047528237 |z (OCoLC)1048131430 |z (OCoLC)1055336146 |z (OCoLC)1063799329 |z (OCoLC)1081257008 |z (OCoLC)1119441791 |z (OCoLC)1119513554 |z (OCoLC)1153503450 |z (OCoLC)1156373658 |z (OCoLC)1162567391 |z (OCoLC)1200916675 |z (OCoLC)1204386208 |z (OCoLC)1204392903 |z (OCoLC)1228577044 |z (OCoLC)1249254461 |z (OCoLC)1290090275 |z (OCoLC)1300705903 |z (OCoLC)1412396172 | ||
| 050 | 4 | |a R853.B54 |b A23 2009eb | |
| 060 | 4 | |a 2009 K-807 | |
| 060 | 4 | |a QV 744 |b I59c 2009 | |
| 072 | 7 | |a MED |x 047000 |2 bisacsh | |
| 072 | 7 | |a MED |x 018000 |2 bisacsh | |
| 072 | 7 | |a MED |x 058020 |2 bisacsh | |
| 072 | 7 | |a K |2 bicssc | |
| 082 | 0 | 4 | |a 616.075 |2 22 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Accelerating the development of biomarkers for drug safety : |b workshop summary / |c Steve Olson, Sally Robinson and Robert Giffin, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
| 260 | |a Washington, D.C. : |b National Academies Press, |c ©2009. | ||
| 300 | |a 1 online resource (xiv, 84 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file | ||
| 520 | |a "Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has risen in recent years, reducing the number of new drugs approved for use, biomarker development may be a way to cut costs, enhance safety, and provide a more focused and rational pathway to drug development. On October 24, 2008, the IOM's Forum on Drug Discovery, Development, and Translation held "Assessing and Accelerating Development of Biomarkers for Drug Safety," a one-day workshop, summarized in this volume, on the value of biomarkers in helping to determine drug safety during development." | ||
| 504 | |a Includes bibliographical references. | ||
| 505 | 0 | |a Introduction -- Overview Of key issues -- Cardiac safety biomarkers -- Assessing and predicting kidney safety -- Biomarkers of acute idiosyncratic hepatocellular injury in clinical trials -- Future considerations. | |
| 588 | 0 | |a Print version record. | |
| 546 | |a English. | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Biochemical markers |v Congresses. | |
| 650 | 0 | |a Drugs |x Safety measures |v Congresses. | |
| 650 | 0 | |a Drugs |x Testing |v Congresses. | |
| 650 | 0 | |a Drugs |x Side effects. | |
| 650 | 0 | |a Biochemical markers. | |
| 650 | 0 | |a Drugs |x Design. | |
| 650 | 1 | 2 | |a Drug-Related Side Effects and Adverse Reactions |
| 650 | 1 | 2 | |a Biomarkers. |
| 650 | 2 | 2 | |a Drug Design |
| 650 | 2 | 2 | |a Drug Discovery |
| 650 | 6 | |a Marqueurs biologiques |v Congrès. | |
| 650 | 6 | |a Médicaments |x Sécurité |x Mesures |v Congrès. | |
| 650 | 6 | |a Médicaments |x Essais cliniques |v Congrès. | |
| 650 | 6 | |a Médicaments |x Effets secondaires. | |
| 650 | 6 | |a Marqueurs biologiques. | |
| 650 | 6 | |a Médicaments |x Conception. | |
| 650 | 7 | |a MEDICAL |x Laboratory Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diagnosis. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Nursing |x Assessment & Diagnosis. |2 bisacsh | |
| 650 | 7 | |a Drugs |x Side effects |2 fast | |
| 650 | 7 | |a Drugs |x Design |2 fast | |
| 650 | 7 | |a Biochemical markers |2 fast | |
| 650 | 7 | |a Drugs |x Safety measures |2 fast | |
| 650 | 7 | |a Drugs |x Testing |2 fast | |
| 655 | 2 | |a Congress | |
| 655 | 7 | |a proceedings (reports) |2 aat | |
| 655 | 7 | |a Conference papers and proceedings |2 fast | |
| 655 | 7 | |a Conference papers and proceedings. |2 lcgft | |
| 655 | 7 | |a Actes de congrès. |2 rvmgf | |
| 700 | 1 | |a Olson, Steve, |d 1956- | |
| 700 | 1 | |a Robinson, Sally. | |
| 700 | 1 | |a Giffin, Robert B. | |
| 710 | 2 | |a Institute of Medicine (U.S.). |b Forum on Drug Discovery, Development, and Translation. | |
| 758 | |i has work: |a Accelerating the development of biomarkers for drug safety (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFQHG6jWvrmhkjWjmWp4G3 |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |a Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation. |t Accelerating the development of biomarkers for drug safety. |d Washington, D.C. : National Academies Press, ©2009 |z 9780309131247 |w (OCoLC)431872188 |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3378514 |z Texto completo |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36615202 | ||
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36558439 | ||
| 938 | |a Coutts Information Services |b COUT |n 10729834 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL3378514 | ||
| 938 | |a EBSCOhost |b EBSC |n 288965 | ||
| 938 | |a YBP Library Services |b YANK |n 3106814 | ||
| 938 | |a Internet Archive |b INAR |n acceleratingdeve0000inst | ||
| 994 | |a 92 |b IZTAP | ||